PDB70 BASELINE CHARACTERISTICS AND ANTIDIABETIC EXPOSURE IN PATIENTS WITH TYPE-2 DIABETES TREATED WITH LIRAGLUTIDE
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.578
https://www.valueinhealthjournal.com/article/S1098-3015(11)00717-0/fulltext
Section Title :
Disease-Specific Studies
Section Order :
32
First Page :
A104
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00717-0&doi=10.1016/j.jval.2011.02.578